For example, the chemokine receptor CXCR-2 is a key regulator of monocyte mobilization in hypertension and heart remodeling; and blocking the activation of CXCR-2 can be used as a new treatment strategy for AF (Zhang et al., 2020). Here, CXCR2 is linked to Hypertension.